# US 2026/0083910 A1 · Insulin delivery methods, systems and devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083910 A1
- Document ID: US20260083910A1
- Status: Published application
- Kind: A1
- Application number: 19/404,597
- Filed: 2025-12-01
- Published: 2026-03-26
- Earliest claimed: 2017-01-13
- Assignees: Insulet Corporation
- Applicants: Insulet Corporation
- Inventors: Bryan Mazlish; Lane Desborough
- Web page: https://patentgrep.com/patent/US20260083910A1

## CPC

- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- G16H 20/17: delivered via infusion or injection
- G16H 40/63: for local operation
- A61B 5/0024: {for multiple sensor units attached to the patient, e.g. using a body or personal area network}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body}
- A61M 2230/201: Glucose concentration
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Methods of insulin delivery may include selecting a basal insulin delivery rate responsive to a projected blood glucose level that approximates a target blood glucose level. Methods of insulin delivery may further include generating insulin delivery instructions for an insulin delivery device, the insulin delivery instructions corresponding to the basal insulin delivery rate and for a variable time duration relative to an intended time duration.

## Claims

### Claim 1

A system, comprising:
a medicament delivery device;
an analyte monitor configured to obtain one or more analyte values in response to a request invoking the analyte monitor received via an interface for short-range wireless communication; and
a controller configured to:
obtain one or more analyte values from the analyte monitor in response to the request invoking the analyte monitor;
operate the medicament delivery device in a closed-loop mode based on the one or more analyte values;
determine whether a predetermined duration of time has passed since a previous request invoking the analyte monitor; and
transition operation of the medicament delivery device from the closed-loop mode to an open-loop mode in response to a determination that the predetermined duration of time has passed since the previous request invoking the analyte monitor.

### Claim 2 (depends on 1)

The system of claim 1, wherein the request invoking the analyte monitor is an action that triggers the analyte monitor to obtain, store or transmit analyte values.

### Claim 3 (depends on 1)

The system of claim 1, wherein the controller is configured to transition operation of the medicament delivery device from the open-loop mode to the closed-loop mode in response to a current request invoking the analyte monitor, the open-loop mode based on a fixed, pre-determined basal rate.

### Claim 4 (depends on 1)

The system of claim 1, wherein the controller is configured to provide an alarm or alert in response to transitioning operation of the medicament delivery device to the open-loop mode due to the predetermined duration of time passing since the previous request invoking the analyte monitor.

### Claim 5 (depends on 1)

The system of claim 1, wherein the interface for short-range wireless communication comprises near field communication (NFC).

### Claim 6 (depends on 1)

The system of claim 1, wherein the interface for short-range wireless communication comprises BLUETOOTH® communication.

### Claim 7 (depends on 1)

The system of claim 1, wherein the controller is integrated with the medicament delivery device.

### Claim 8 (depends on 1)

The system of claim 1, wherein the controller comprises a separate device from the medicament delivery device.

### Claim 9 (depends on 1)

The system of claim 1, wherein the predetermined duration of time defines a duration after which the one or more analyte values become stale.

### Claim 10

A method, comprising:
obtaining one or more analyte values from an analyte monitor in response to a request invoking the analyte monitor via an interface for short-range wireless communication;
operating a medicament delivery device in a closed-loop mode based on the one or more analyte values;
determining whether a predetermined duration of time has passed since a previous request invoking the analyte monitor; and
transitioning operation of the medicament delivery device from the closed-loop mode to an open-loop mode in response to a determination that the predetermined duration of time has passed since the previous request invoking the analyte monitor.

### Claim 11 (depends on 10)

The method of claim 10, wherein the request invoking the analyte monitor comprises an action triggering the analyte monitor to obtain, store or transmit analyte values.

### Claim 12 (depends on 11)

The method of claim 11, comprising:
transitioning operation of the medicament delivery device from the open-loop mode to the closed-loop mode in response to a current request invoking the analyte monitor, the open-loop mode based on a fixed, pre-determined basal rate.

### Claim 13 (depends on 11)

The method of claim 11, comprising:
providing an alarm or alert in response to transitioning operation of the medicament delivery device to the open-loop mode due to the predetermined duration of time passing since the previous request invoking the analyte monitor.

### Claim 14 (depends on 11)

The method of claim 11, wherein the interface for short-range wireless communication comprises near field communication (NFC).

### Claim 15 (depends on 11)

The method of claim 11, wherein the interface for short-range wireless communication comprises BLUETOOTH® communication.

### Claim 16 (depends on 11)

The method of claim 11, wherein the predetermined duration of time defining a duration after which the one or more analyte values become stale.
